Last10K.com

Novartis Ag (NVS) SEC Filing 20-F Annual Report for the fiscal year ending Friday, December 31, 2021

SEC Filings

NVS Annual Reports

  • 20-F Annual Report February 2022
  • 20-F Annual Report January 2021
    20-F Annual Report January 2020
    20-F Annual Report January 2019
    20-F Annual Report January 2018
    20-F Annual Report January 2017
    20-F Annual Report January 2016
    20-F Annual Report January 2015
    20-F Annual Report January 2014

Novartis Ag

CIK: 1114448 Ticker: NVS

View differences made from one year to another to evaluate Novartis Ag's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Novartis Ag.

Continue

Assess how Novartis Ag's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Novartis Ag's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Cash Flow Statements
Consolidated Income Statements
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Comprehensive Income
Acquisitions Of Businesses
Acquisitions Of Businesses (Details)
Acquisitions Of Businesses (Tables)
Associated Companies
Associated Companies (Details 2)
Associated Companies (Details 3)
Associated Companies (Details 4)
Associated Companies (Details 6)
Associated Companies (Details)
Associated Companies (Tables)
Changes In Consolidated Statements Of Comprehensive Income
Changes In Consolidated Statements Of Comprehensive Income (Details)
Changes In Consolidated Statements Of Comprehensive Income (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details 2)
Commitments And Contingencies (Tables)
Current Financial Debt And Derivative Financial Instruments
Current Financial Debt And Derivative Financial Instruments (Details)
Current Financial Debt And Derivative Financial Instruments (Tables)
Deferred Tax Assets And Liabilities
Deferred Tax Assets And Liabilities (Details 3)
Deferred Tax Assets And Liabilities (Details 4)
Deferred Tax Assets And Liabilities (Details 5)
Deferred Tax Assets And Liabilities (Details)
Deferred Tax Assets And Liabilities (Tables)
Details To The Consolidated Cash Flow Statements (Details 2)
Details To The Consolidated Cash Flow Statements (Details 3)
Details To The Consolidated Cash Flow Statements (Details 6)
Details To The Consolidated Cash Flow Statements (Details 7)
Details To The Consolidated Cash Flow Statements (Details)
Details To The Consolidated Statements Of Cash Flows
Details To The Consolidated Statements Of Cash Flows (Tables)
Discontinued Operations
Discontinued Operations (Details 2)
Discontinued Operations (Details 4)
Discontinued Operations (Details 8)
Discontinued Operations (Details 9)
Discontinued Operations (Details)
Discontinued Operations (Tables)
Earnings Per Share
Earnings Per Share (Details)
Earnings Per Share (Tables)
Equity
Equity (Details 2)
Equity (Details 3)
Equity (Details 4)
Equity (Details 5)
Equity (Details)
Equity (Tables)
Equity-Based Participation Plans For Employees
Equity-Based Participation Plans For Employees (Details 2)
Equity-Based Participation Plans For Employees (Details 3)
Equity-Based Participation Plans For Employees (Details 4)
Equity-Based Participation Plans For Employees (Details 5)
Equity-Based Participation Plans For Employees (Details)
Equity-Based Participation Plans For Employees (Tables)
Events Subsequent To The December 31 Consolidated Balance Sheet Date
Events Subsequent To The December 31 Consolidated Balance Sheet Date (Details)
Financial And Other Non-Current Assets
Financial And Other Non-Current Assets (Details 2)
Financial And Other Non-Current Assets (Details)
Financial And Other Non-Current Assets (Tables)
Financial Instruments - Additional Disclosures
Financial Instruments - Additional Disclosures (Details 10)
Financial Instruments - Additional Disclosures (Details 12)
Financial Instruments - Additional Disclosures (Details 13)
Financial Instruments - Additional Disclosures (Details 14)
Financial Instruments - Additional Disclosures (Details 15)
Financial Instruments - Additional Disclosures (Details 16)
Financial Instruments - Additional Disclosures (Details 2)
Financial Instruments - Additional Disclosures (Details 3)
Financial Instruments - Additional Disclosures (Details 4)
Financial Instruments - Additional Disclosures (Details 5)
Financial Instruments - Additional Disclosures (Details 6)
Financial Instruments - Additional Disclosures (Details 7)
Financial Instruments - Additional Disclosures (Details 8)
Financial Instruments - Additional Disclosures (Details 9)
Financial Instruments - Additional Disclosures (Details)
Financial Instruments - Additional Disclosures (Tables)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (Details 2)
Goodwill And Intangible Assets (Details 3)
Goodwill And Intangible Assets (Details 4)
Goodwill And Intangible Assets (Details)
Goodwill And Intangible Assets (Tables)
Income Taxes
Income Taxes (Details 2)
Income Taxes (Details 3)
Income Taxes (Details)
Income Taxes (Tables)
Interest Expense And Other Financial Income And Expense
Interest Expense And Other Financial Income And Expense (Details 2)
Interest Expense And Other Financial Income And Expense (Details)
Interest Expense And Other Financial Income And Expense (Tables)
Inventories
Inventories (Details)
Inventories (Tables)
Lease Liability And Right-Of-Use Assets (Details 2)
Lease Liability And Right-Of-Use Assets (Details 3)
Lease Liability And Right-Of-Use Assets (Details 4)
Lease Liability And Right-Of-Use Assets (Details 5)
Lease Liability And Right-Of-Use Assets (Details 6)
Marketable Securities, Commodities, Time Deposits, Derivative Financial Instruments And Cash And Cash Equivalents
Marketable Securities, Commodities, Time Deposits, Derivative Financial Instruments And Cash And Cash Equivalents (Details 3)
Marketable Securities, Commodities, Time Deposits, Derivative Financial Instruments And Cash And Cash Equivalents (Details)
Marketable Securities, Commodities, Time Deposits, Derivative Financial Instruments And Cash And Cash Equivalents (Tables)
Non-Current Financial Debt
Non-Current Financial Debt (Details 2)
Non-Current Financial Debt (Details 3)
Non-Current Financial Debt (Details 4)
Non-Current Financial Debt (Details 5)
Non-Current Financial Debt (Details)
Non-Current Financial Debt (Tables)
Other Current Assets
Other Current Assets (Details)
Other Current Assets (Tables)
Post-Employment Benefits For Employees
Post-Employment Benefits For Employees (Details 10)
Post-Employment Benefits For Employees (Details 2)
Post-Employment Benefits For Employees (Details 3)
Post-Employment Benefits For Employees (Details 4)
Post-Employment Benefits For Employees (Details 5)
Post-Employment Benefits For Employees (Details 6)
Post-Employment Benefits For Employees (Details 7)
Post-Employment Benefits For Employees (Details 8)
Post-Employment Benefits For Employees (Details 9)
Post-Employment Benefits For Employees (Details)
Post-Employment Benefits For Employees (Tables)
Principal Group Subsidiaries And Associated Companies
Principal Group Subsidiaries And Associated Companies (Details)
Principal Group Subsidiaries And Associated Companies (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Details 2)
Property, Plant And Equipment (Details)
Property, Plant And Equipment (Tables)
Provisions And Other Current Liabilities
Provisions And Other Current Liabilities (Details 2)
Provisions And Other Current Liabilities (Details 3)
Provisions And Other Current Liabilities (Details)
Provisions And Other Current Liabilities (Tables)
Provisions And Other Non-Current Liabilities
Provisions And Other Non-Current Liabilities (Details 2)
Provisions And Other Non-Current Liabilities (Details 3)
Provisions And Other Non-Current Liabilities (Details 4)
Provisions And Other Non-Current Liabilities (Details 5)
Provisions And Other Non-Current Liabilities (Details)
Provisions And Other Non-Current Liabilities (Tables)
Right-Of-Use Assets And Lease Liabilities
Right-Of-Use Assets And Lease Liabilities (Tables)
Segmentation Of Key Figures
Segmentation Of Key Figures (Details 1)
Segmentation Of Key Figures (Details 10)
Segmentation Of Key Figures (Details 11)
Segmentation Of Key Figures (Details 2)
Segmentation Of Key Figures (Details 3)
Segmentation Of Key Figures (Details 4)
Segmentation Of Key Figures (Details 5)
Segmentation Of Key Figures (Details 6)
Segmentation Of Key Figures (Details 8)
Segmentation Of Key Figures (Details)
Segmentation Of Key Figures (Tables)
Segmentation Of Key Figures - Net Sales By Region (Details 7)
Segmentation Of Key Figures - Top 20 (Details 9)
Significant Accounting Policies
Significant Accounting Policies (Details)
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Significant Transactions
Significant Transactions (Details 2)
Significant Transactions (Details)
Significant Transactions (Tables)
Trade Receivables
Trade Receivables (Details 2)
Trade Receivables (Details 3)
Trade Receivables (Details 4)
Trade Receivables (Details 5)
Trade Receivables (Details)
Trade Receivables (Tables)
Transaction With Related Parties (Details 1)
Transactions With Related Parties
Transactions With Related Parties (Details 2)
Transactions With Related Parties (Details 3)
Transactions With Related Parties (Tables)
Ticker: NVS
CIK: 1114448
Form Type: 20-F Annual Report
Accession Number: 0001370368-22-000010
Submitted to the SEC: Wed Feb 02 2022 7:31:11 AM EST
Accepted by the SEC: Wed Feb 02 2022
Period: Friday, December 31, 2021
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nvs/0001370368-22-000010.htm